A mobile phone app designed to deliver suicide-specific therapy reduced suicidal behavior among high-risk psychiatric inpatients, according to a new study by scientists at Yale School of Medicine and The Ohio State University Wexner Medical Center and College of Medicine.

Organic molecules that combine efficient light emission for displays and strong light absorption for bioimaging are difficult to design due to conflicting structural requirements. Researchers from Japan addressed this challenge by developing CzTRZCN, a single molecule that switches structure depending on light interaction, enabling both two-photon absorption and thermally activated delayed fluorescence. These dual functions are useful in OLEDs and biomedical imaging, paving the way for versatile organic materials in electronics, medicine, and life sciences.

Undocumented immigrants have limited insurance coverage after birthing. During the COVID-19 pandemic, New York City extended Medicaid coverage for residents, including immigrants, beyond the normal 60-day period. Now a study has found that this policy changes reduced inequities in health coverage in the postpartum period between immigrants and US-born residents in the city. The reduction in insurance coverage inequity among the Hispanic population was the least compared to other racial groups.

The Barcelona Institute for Global Health (ISGlobal), a centre supported by the ”la Caixa” Foundation, has launched HTGAnalyzer, a new, easy-to-use, fast and reproducible bioinformatics tool for advanced transcriptomic data analysis. Designed within the R statistical environment, this package simplifies complex analytical processes, making them accessible to professionals without specific expertise in bioinformatics.

The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the establishment of a Commission comprising a wide range of medical and public health experts. Now, they present their findings in a recent report, which defines concrete goals for the reduction of hepatocellular carcinoma cases, and presents a set of evidence-based recommendations to help stakeholders work together to achieve these goals.